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ABSTRACT
We have developed a RecA-mediated simple, rapid
and scalable method for identifying novel alter-
natively spliced full-length cDNA candidates. This
method is based on the principle that RecA proteins
allow to carry radioisotope-labeled probe DNAs to
their homologous sequences, resulting in forming
triplexes. The resulting complex is easily detected
by mobility difference on electrophoresis. We applied
this exon profiling method to four selected mouse
genes as a feasibility study. To design probes for
detection, the information on known exonic regions
was extracted from public database, RefSeq.
Concerning the potentially transcribed novel exonic
regions, RNA mapping experiment using Affymetrix
tiling array was performed. As a result, we were able
to identify alternative splice variants of Thioredoxin
domain containing 5, Interleukin1b,I n t e r l e u k i n1
family 6 and glutamine-rich hypothetical protein. In
addition, full-length sequencing demonstrated that
our method could profile exon structures with .90%
accuracy. This reliable method can allow us to
screen novel splice variants from a huge number of
cDNA clone set effectively.
INTRODUCTION
It is known that most mammalian genes are subjected to
alternatively splicing, probably to maximize the diversity
of proteins from the unexpectedly small number of genes
encoded by the genome (1–4). Many alternative splicing tran-
scripts have been reported to play critical roles in living cells,
e.g. in disease cascades (5,6). Conventionally, pairwise com-
parison of full-length cDNAs (7–12) and expressed sequence
tags (ESTs) have been used to identify alternative transcripts.
As a tool for expression proﬁling analysis, DNA microarray
was innovated (13) and has been a widely used tool in ﬁnd-
ing responsible genes for various diseases (14). Recently,
exon junction arrays (15) and oligonucleotide tiling arrays
(10,16–19) have also been employed to study alternatively
spliced transcripts. More recently, the newly developed exon
arrays promise to identify alternative exons genome-wide.
Although these methods are powerful tools to help us to iden-
tify individual alternative exons, it is still difﬁcult to deter-
mine the entire exon structure including the information on
exon boundaries, which is indispensable for functional anal-
ysis. From this aspect, collecting physical cDNAs is still the
only solution for acquiring the whole structure of transcripts.
With the aim to describe the whole picture of trans-
criptome, several cDNA projects have been conducted inten-
sively. They, however, emphasize on identifying novel genes,
and most of collected cDNA clones were clustered based
on their EST information and stored without being fully
sequenced. In the case of our RIKEN full-length mouse
cDNA project and FANTOM activities (20,21), a few mil-
lions of full-length enriched cDNA clones have been col-
lected, but only  100000 representative cDNA clones were
fully sequenced and functionally annotated. This fact implies
that current cDNA projects unveiled just one tiny part of the
transcriptome. In addition, recent analyses showed that >40%
of genes were subjected to alternative splicing, producing
various protein isoforms (12,22,23). Taken together, a huge
number of splice variants are potentially stored among clus-
tered cDNA clones.
To shed light on potential alternative splice variants within
the huge cDNA clone set, the most accurate and reliable
way is to determine the entire sequence of all transcripts
by sequencing. However, it is time-consuming and cost-
consuming procedure and far from the reality. At present,
$100000 and $1000 genome projects are ongoing to develop
next-generation type sequencers. Some pioneering sequencers
are getting available (24), but these sequencers usually take
shotgun-like sequencing strategy and would not be suitable
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doi:10.1093/nar/gkl497for full-length cDNA sequencing since it requires the corre-
spondence of each clone to each sequence data. Therefore,
if a novel and simple method for exon proﬁling is available,
it would be useful to screen alternatively spliced transcripts
from the huge cDNA clone set.
To this end, we have developed a simple RecA-mediated
exon proﬁling method to investigate exon structures without
sequencing. In this method, the sequence-speciﬁcity of
homologous recombinase, RecA protein, was utilized (25–
27). Radioisotope-labeled ‘probe’ oligonucleotides were ﬁrst
carried to their homologous sequences by RecA protein in
a sequence-speciﬁc manner, resulting in pairing at the same
sequences between the single-stranded (ss) and double-
stranded (ds) DNA molecules. Although there is no stable
triple-stranded DNA formation since RecA ﬁlaments within
the strands are already exchanged (28), we call the paired
DNA complexes as ‘triplex’. The triplexes were detected by
mobility difference on electrophoresis. Full-length sequenc-
ing demonstrated that our method was able to detect exonic
regions with high accuracy. Moreover, several novel splice
variants were successfully identiﬁed with this method. Here
we report the principle of the simple and reliable RecA-
mediated method for exon proﬁling.
MATERIALS AND METHODS
The sequence information on fully sequenced cDNAs in this
study has been deposited to DDBJ with the library name,
RMEP. DDBJ accession nos ¼ AK224911-AK225023.
Optimization of RecA-mediated exon profiling
conditions
Oligonucleotides and target DNA. Oligonucleotides with
identical and non-identical sequences to pUC19 (‘Target’
DNA) were designed from 10mer to 50mer with the incre-
ment of 10 bases. The pUC19 was used as a model to opti-
mize the detection conditions. The oligonucleotides for
detection are deﬁned as probes in this study. After designing
probes, a BLAST search (29) was performed to investigate
whether unintended homologous sequences were present in
target DNA sequence. To avoid cross hybridization, the most
speciﬁc probes to the target sequences were carefully selected.
The probe sequences are listed in Supplementary Table S1.
The pUC19 DNA was puriﬁed with Mini Prep kit according
to the manufacture’s protocol (Qiagen). Oligonucleotides
were purchased from Operon Biotechnology, Inc.
Labeling of oligonucleotides. Oligonucleotides were labeled
at the 50-terminus with T4 polynucleotide kinase (TaKaRa-
Bio) in the presence of [g-
32P]ATP (3000 Ci/mmol; GE
Healthcare Bio-Sciences Corp.) by incubating for 30 min at
37 C. To terminate the labeling reaction and to purify,
50 ml of resultant mixture was, then, mixed with 1 mlo f
0.5 M EDTA, 1 ml of 10% SDS, and 1 ml of 20 mg/ml
Proteinase K and incubated for 30 min at 45 C followed by
phenol-chloroform extraction. Then, the puriﬁed labeled
DNA solution was applied to Microspin S-400 HR columns
(GE Healthcare Bio-Sciences Corp.) to remove excess of
[g-
32P]ATP.
The RecA-mediated triplex formation analysis. The probe
DNAs were diluted to  1 pmol/l and the triplex formation
reaction was performed in 20 ml of the solution containing
25 mM Tris–acetate, 5 mM Magnesium acetate, 1 mM DTT
and 0.1 mM ATPgS (Roche Diagnostics), 3 mgo f
Escherichia coli RecA protein (New England Biolabs) and
50 ng of pUC19 plasmid. The reaction mixture was incubated
for 1 h at 37 C. The reaction was terminated by placing on
ice and adding 6· loading dye, which is composed of
10 mM Tris–HCl (pH 7.6), 0.03% bromophenol blue,
0.03% xylene cyanol FF, 60% glycerol and 60 mM EDTA;
and then it was followed by 1.2% agarose gel electrophoresis
in 1· TAE buffer. The gel was dried with a gel drier (Bio-Rad
Laboratories), and exposed to an IP sheet (Fuji Photo Film
Co., Ltd) for 3–5 h. The exposed sheet was analyzed by
BAS2500 (Fuji Photo Film Co., Ltd).
The RecA-mediated exon profiling analysis using
RIKEN clone sets
Selection of drug-related genes from the RIKEN Clone Bank.
The RIKEN clone sets were used for this analysis. Four
human genes, which were related to commercially available
drugs, were randomly selected. With the sequences of these
four drug-related genes, the mouse orthologs to these genes
were searched with HomoloGene (http://www.ncbi.nlm.nih.
gov/entrez/query.fcgi?db¼homologene). The RIKEN cDNA
clones corresponding to these mouse orthologs were compu-
tationally identiﬁed using their gene locus information. When
necessary, Gene Ontology information was used to select
the RIKEN cDNA clones that included similar functional
domains to drug-related genes. The E.coli carrying the
selected cDNA sequences in plasmids were cultivated, and
the plasmids were puriﬁed with Qiagen Mini preparation kit
(Qiagen) for further analyses.
RNA mapping experiment with tiling arrays. To obtain the
information on novel exon candidates, we used the GeneChip
Mouse Tiling Array ver. 1.0 (Affymetrix). The RNAs, which
were used for cDNA library construction in the RIKEN
mouse encyclopedia project, were utilized for microarray-
based RNA mapping. A total of 66 different RNA samples
with the same amount were mixed and 10 mg of the mixed
RNA were used for hybridization. The tissue/cell names
of the mixed 66 RNAs are provided in Supplementary
Table S2. The ﬁrst-strand cDNA was synthesized with ran-
dom primers using SuperScript II (Invitrogen). The resulting
cDNAs were then used as template for the second-strand
cDNA synthesis under conditions described in the manufac-
ture’s protocol. After the second-strand synthesis, the remain-
ing RNAs were degraded using a combination of RNaseA/T1
cocktail (Ambion) and RNaseH (Ambion). The dscDNAs
were then puriﬁed with PCR puriﬁcation kit (Qiagen, Inc.)
and fragmented with DNase I, and end-labeled with biotin
as described previously (10). One set of whole genomic tiling
array comprises 16 separate chips. For each chip,  4 mgo f
the end-labeled cDNA samples were applied. The labeled
DNAs were hybridized to the array chips for 16–18 h at
45 C. The array chips were washed as per the manufacture’s
protocol, and scanned using a GeneChip Scanner 3000 7G
(Affymetrix, Inc). The hybridization experiments were
carried out in duplicate.
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The signal intensity at each probe was computed using the
Affymetrix software, TAS. A Wilcoxon signed-rank test was
applied to the hybridization intensities (background-subtracted
intensity, PM–MM, where PM and MM indicate intensities
detected by a pair of 25mers matching perfectly and one base
mismatching to the genome, respectively) measured at probes
located within ±50 bp of every probe location. The pseudo
median generated by the Wilcoxon test was assigned as an esti-
mate of the signal intensity to the probe position. The signal
intensity was given on log2 scale as shown in Figure 3.
The graphs from these processed data were generated
by INTEGRATED GENOME BROWSER software
(Affymetrix, Inc.). The transfrags, genomic regions where a
signiﬁcant level of expression was detected, were identiﬁed
by joining positive probes (signal intensity >7.4) separated
by less than a certain distance (maxgap ¼ 100 bp) and select-
ing regions with an extension of >30 bp (minrun).
Probe design and exon profiling analysis. Oligonucleotide
probes were designed according to the following work order:
(i) Extraction of known and candidate exonic regions for the
drug-related genes from RefSeq and transfrag data (transcrip-
tional fragments data from tiling arrays). (ii) Designing of all
possible combinations of 30mer oligonucleotide sequence
probes within each extracted exonic region. (iii) Comparison
ofeach30meroligonucleotidesequencewiththecloningvector
sequence by BLAST. The most speciﬁc oligonucleotide
sequences for detection were chosen. All oligonucleotides
were purchased from Operon Biotechnology, and the probes
for RIKEN clone sets were prepared as described above. Exon
proﬁling for RIKEN clone sets was performed as described
above, exceptthat 96-well plates were used (Abgene,Inc.).
Full-length cDNA sequence determination. All cDNA clones
clustered within the Txndc5 locus and all alternative splice
variant candidates in IL-1b, IL-1F6 and glutamine-rich hypo-
thetical protein (GR) were fully sequenced by using an
ABI3700 capillary sequencer (Applied Biosystems) and Big
Dye terminator sequencing kit (Applied Biosystems). For
sequencing, primers were designed for every 300 bp on the
sequence of fully sequenced representative clones. Their seq-
uences were base-called by Phred (30) and assembled by
Phrap (31).
Further characterization of newly identiﬁed splice variants.
The sequences of splice variant candidates were compared
to sequences in genetic databases; GeneBank, the Mouse
Genome Database and TIGR databases. The comparison was
performed using the nucleotide-to-nucleotide sequence local
alignment algorithm, BLASTN. In addition, deduced amino
acid sequences for longest ORF were computationally deter-
mined. Finally, the splice variant candidates were analyzed
with the SCOP (32), Pfam (33) and InterPro (34,35) programs
for identifying potential functional domains. SOSUI program
(36) was also applied for transmembrane protein prediction.
RESULTS
Principle of RecA-mediated exon profiling method
In this study, radioisotope-labeled ss oligonucleotides were
deﬁned as probes, and dsDNAs containing their homologous
sequences were called as targets. The principle of our simple
exon proﬁling method utilizing RecA protein is described
in Figure 1. At the ﬁrst step, radioisotope-labeled oligonu-
cleotide probes were incubated with RecA protein and
Adenosine 50-O-(3-thio)triphosphate (ATPgS), which stabi-
lizes the interaction of a short ss oligonucleotide with
dsDNA (37,38). The resulting complex was further incubated
with dsDNA to pair with its homologous sequence. And
then, the paired complex, ‘triplex’ formation was evaluated
by mobility difference on agarose electrophoresis and by
autoradiography.
Examination of probe length in RecA-mediated exon
profiling method
Our computational analysis using the FANTOM cDNA clone
set showed that out of 126322 internal exons  93% of the
exons were longer than 50 bp and 99.3% of the exons were
longer than 30 bp (S. Kondo, unpublished data), indicating
that the detection for exons shorter than 50 bp is required.
To determine the minimum probe length in our method,
various probes in length were examined using pUC19 as a
target dsDNA.
3’
3’
Clone 1 Clone 2
=triplex formation
triplex
Figure 1. Principle of RecA-mediated exon profiling method. Oligonucleo-
tides were designed for exon candidate regions. (a) Incubation of the labeled
oligonucletides (probes) with RecA, ATPgS and Mg
2+ for 5 min at 37 C.
(b) Incubation for 1 h at 37 C after adding dsDNA (e.g. pUC19) to the
reaction mixture. (c) Electrophoresis and autoradiography for detection. The
shifted band with slower migration represents triplex formation, indicating
the presence of the sequence corresponding to the probe (arrow I). The bands
for the probes without forming the triplex are represented as faster migration
(arrow II).
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32P at the 50 end was
incubated with RecA, ATPgS and pUC19 DNA, as described
in Materials and Methods. The resultant products were elec-
trophoresed, and signals were detected by autoradiography.
As shown in Figure 2, the RecA-mediated triplex formation
corresponding to the presence of probe sequence was detected
with mobility difference on electrophoresis. Although the
signals derived from triplexes were detected down to 10mer
probes, the signals using 20mer and 10mer probes were
faint and seemed not to be reliable (Figure 2, lanes 7 and
9). As for non-homologous probes, no mobility change was
detected (Figure 2, lanes 2, 4, 6, 8 and 10), indicating
that triplex formation with pUC19 DNA occurred in a
sequence-speciﬁc manner. In addition, it was also veriﬁed
that the triplex formation took place in a RecA protein-
dependent manner (Figure 2, lane 11). Altogether, we decided
to utilize 30mer probes for further analyses, and it means
that our method is able to detect >99% of internal exons
theoretically.
Selection of gene loci for evaluation
To evaluate the RecA-mediated exon proﬁling method, we
next selected four drug-related gene loci for exon proﬁling
from the RIKEN clone bank: Thioredoxin domain containing
5 (Txndc5), Interleukin1 beta (IL-1b), Interleukin 1 family 6
(IL-1F6) and glutamine-rich hypothetical protein. Through
our FANTOM activity, all collected cDNA clones were
clustered with their EST information on their genomic loci,
intending to encompass all overlapping transcripts derived
from the same strand of a single gene locus (21). These clus-
ters are called as transcriptional units (TUs) (21). All cDNA
clones clustered within the four selected TUs were computa-
tionally identiﬁed. As shown in Table 1, a total of 139 clones
were clustered into the four loci, and the Txndc5, IL-1b,
IL-1F6 and glutamine-rich hypothetical protein loci con-
tained 95, 14, 17 and 13 clones, respectively (Table 1 and
Supplementary Tables S7–S10).
Extraction of known exons and candidate exons
To design probes for exon proﬁling, all exons were divided
into two categories: known exons and candidate exons. The
known exons were extracted in silico from RefSeq for the
four gene loci. As for the candidate exons, RNA mapping
using Affymetrix mouse whole genome tiling array was per-
formed. The RNAs from 66 different tissues/cells were mixed
and used for hybridization. We generated the signal intensity
using the standard tiling array protocol implemented in the
Affymetrix software, TAS (17). The transcription fragments
(transfrags) with signal intensity above 7.4 on four different
loci were generated as potentially transcribed regions. The
transfrags, RefSeq and the RIKEN FANTOM representative
clones were aligned on Affymetrix IGB viewer, and the
genomic positions of transfrags and those of the known
exons from RefSeq and fully sequenced representative clones
were compared (Figure 3). The transfrags, which did not
overlap with any known exons or which were different in
length from the known exons, were considered as novel
Probe Length
[mer]
23.1
12345678 9 1 0 1 1
RecA
Probe type
++ ++ + + + + + +-
PPPP P P NNN N N
50 40 30 20 10 50
(kb)
0.56
Lane #
2.3
Figure 2. Examination of probe length with RecA-mediated exon profiling
method. Two sets of 50, 40, 30, 20 and 10mer probes were prepared; identical
(P) and non-identical (N) to pUC19 DNA. Identical (P) probes with 50, 40,
30, 20 and 10mer probes were examined in lanes 1, 3, 5, 7 and 9, respectively.
Non-identical (N) probes with 50, 40, 30, 20 and 10mer were examined in
lanes 2, 4, 6, 8 and 10, respectively. In lane 11, the reaction without RecA
protein was examined. Open box indicates the position of the band
corresponding to triplex. The DNA size marker (lHind III digests) is shown
at the left with the approximate molecular sizes in kb. The sequences for all
the probes are listed in Supplementary Table S1.
Table 1. Summary of exon profiling
Annotated name/Gene ID/symbol Total
clones
Total
exons
Novel exon
candidate
Total
probes
Total
assays
Thioredoxin domain containing 5
(Txndc5)/105245/Txndc5
95 10 3 16 1520
Interleukin 1 beta
(IL-1b)/16176/Il1b
14 7 2 14 196
Interleukin 1 family, member 6/
(IL1-F6)/54448/Il1f6
17 6 3 14 238
glutamine-rich hypothetical protein
(GR)/73332
/1700041C02Rik
13 22 28 50 650
Total 139 45 36 94 2604
Interleukin 1 beta
Figure 3. Selection of novel exon candidates. IL-1b locus is shown as an
example. Exon structures of RefSeq, RIKEN full-length cDNA clone and
transfrags from tiling array experiments are aligned. Profile of signal intensity
by tiling array is shown in the middle. Exons and introns are represented by
closed boxes and lines. The transfrags were generated from the array data at
signal intensity 7.4. The transfrags which did not overlap with any known
exonic regions were considered as novel exon candidates (striped boxes).
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each gene is summarized in Table 1.
Although RNA mapping data using tiling arrays can
include false positive transfrags, all transfrag data were
used for designing probes because the purpose of this study
was to identify alternatively splice variants as many as possi-
ble. Within the selected four gene loci, the number of the
known exons was 45, and that of novel exon candidates
was 36. In this study, one 30mer probe was designed for
each 100 bp. If an exon exceeded 100 bp in length, each
probe was designed near the ends of exons to improve the
efﬁciency of detection for different exon length. For the
four gene loci, 58 probes and 36 probes were designed for
known exons and novel candidate exons, respectively.
Evaluation of RecA-mediated exon profiling
As the ﬁrst step, we evaluated our RecA-mediated exon pro-
ﬁling method by using the RIKEN cDNA clones clustered
within Txndc5 locus. In this locus, 95 RIKEN cDNA clones
were entried (Supplementary Table S7). For exon proﬁling,
13 probes for 10 known exons and 3 probes for 3 novel
candidate exons were designed with following the rule
described above. The probe sequences are represented in
Supplementary Table S3. In total, 1520 assays (¼95 cDNA
clones · 16 probes) were performed with the RecA-mediated
method. One typical result is shown in Figure 4b. To evaluate
the method precisely, the full-length sequences of the 95
cDNA clones were determined by sequencing and were com-
pared with the results from our method. Out of 95 cDNA
clones, 25 clones were alternative splice variants.
In this study, the speciﬁcity was deﬁned as ‘the number
of assays in which the presence/absence of probe sequences
was correctly detected by our method’ over ‘the number of
total assays’. Concerning the sensitivity, it was deﬁned as
‘the number of assays in which triple-stranded complex
formations were detected by RecA-mediated method’ over
‘the number of assays in which triplex formations should
be detected due to full-length sequencing’. With these deﬁni-
tions, the speciﬁcity and the sensitivity of our RecA-mediated
method were calculated as 93.3% [(1520)   (15 + 86)]/
(1520) and 91.9% (976/1062), respectively. Result is summa-
rized in Table 2.
Identification of alternative splice variants on three
selected gene loci
Since the reliability of this method could be conﬁrmed as
above, we further applied this method to three other selected
gene loci, IL-1b, IL-1F6 and glutamine-rich hypothetical
protein. As for these three gene loci, only splice variant can-
didates which were selected by the RecA-mediated method
were fully sequenced. The result of the exon proﬁling on
these three loci was summarized in Table 3.
In IL-1b locus, 12 probes for known exons and 2 probes for
novel exon candidates were designed (Figure 5a), and 14
cDNA clones were subjected to exon proﬁling. The probe
sequences and the list of clone IDs are provided in Supple-
mentary Tables S4 and S8, respectively. The exon proﬁling
experiment suggested that three clones were alternative splice
variants. In one of these splice variant candidates, triplex
formation was detected for the probe 3, which was designed
on a predicted novel exon (Figure 5b, lane 13). Following
full-length sequencing demonstrated that an intron reten-
tion phenomenon was successfully detected (clone 13 in
Figure 5b–d), and that this cDNA clone (F830203M10) was
conﬁrmed to be a novel alternative splice variant. It should
be a signiﬁcant example for the combination of RNA
Figure 4. Exon profiling in the Txndc5 locus. (a) Exon structure of a known
clone (GeneID: 105245) in the Txndc5 locus is represented in arbitrary scale.
Boxes and lines represent exons and introns, respectively. Closed boxes
indicate the region of protein-coding sequence. Solid lines above exonic
regions indicate probes. Striped boxes represent novel exon candidates. (b)
Typical result of RecA-mediated exon profiling method. The result using
probe 2 designed on the first exon is represented. In the table, circles and
crosses indicate presence and absence of the triplex formation, respectively.
(c) Schematic presentation of the first exons of Txndc5 clones. To clarify the
figure, 15 clones were randomly selected. The probe 2 designed on exon 1 is
indicated with the line in gray. The clones 7, 9 and 10 with underlines were
proved to use an alternative exon downstream as a first exon.
Table 2. Summary of exon profiling on Thioredoxin domain containing 5
locus
Thioredoxin domain containing 5
Specificity 1419/1520 93.3%
Sensitivity 976/1062 91.9%
Number of newly identified splice patterns 13
Number of newly identified splice variants 25
Table 3. Summary of exon profiling on IL-1b, IL-1F6 and glutamine-rich
hypothetical protein
Locus name IL-1b IL-1F6 GR
Number of splice variant candidates 3 2 7
Number of newly identified splice patterns 2 1 3
Number of newly identified splice variants 2 2 4
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cerning the remaining two candidates, the probe (Probe 5)
designed on the known exon (Exon 4) did show no triplex
formation, implying the lack of the corresponding exon
(Figure 5a and c, lanes 2 and 4). However, sequencing data
showed that one of the clones (I830007B19) was wrongly
selected by the RecA-mediated method and was identical to
the known cDNA, and that other one (I830083A07) lacked
ﬁrst four exons out of seven exons and was proved to be a
genuine splice variant (Figures 5d and 6a).
In IL-1F6 locus, 11 probes on 6 known exons and 3 probes
on 3 transfrags, and 17 cDNA clones were employed to
exon proﬁling (Supplementary Tables S5 and S9). Out of
17 clones, 2 clones were detected as alternatively splice
candidates with lacking the sequence of probe 6 designed
on exon 4. Full-length sequence demonstrated that the two
clones (Supplementary Figure S2, lanes 1 and 11) lacking
the exon 4 were identical to each other even at the nucleotide
level. Compared with the sequence of the known cDNAs,
these two were proved to be novel splice variants (Figure 6b).
Concerning the glutamine-rich hypothetical protein locus,
13 cDNA clones were clustered into this locus, and 22 probes
on 22 known exons and 28 probes on 28 novel exon
candidates were designed for exon proﬁling (Supplementary
Tables S6 and S10). In this locus, eight different splice
patterns were already reported. The RecA-mediated exon pro-
ﬁling suggested that seven clones had different splice patterns
from the reported ones. Out of these seven clones, four clones
were bona ﬁde novel splice variants. Two of the four
clones showed the same splice pattern each other, resulting
in identifying three novel splice patterns (Supplementary
Figure S3).
Altogether, RecA-mediated exon proﬁling analysis could
identify eight alternative splice variants from two, two and
four clones of IL1b, IL-1F6 and glutamine-rich hypothetical
protein, respectively.
Figure 6. Exon structures of known transcript and of sequenced alternative
splice variant candidates. Known transcript is represented at top. Boxes and
lines represent exons and introns, respectively. Closed boxes indicate the
region of protein-coding sequence. Squares with dotted lines indicate genuine
alternative splice variants. Positions of domains predicted by InterPro are
indicated with double-headed arrows. (a) In IL1-b locus. (b) In IL-1F6
(GeneID: 54448) locus.
Figure 5. Exon profiling of IL-1b.( a) Exon structure of a representative
clone (GeneID: 16176) in IL1-b locus. Boxes and lines represent exons and
introns, respectively. Closed boxes indicate the region of protein-coding
sequence. Solid lines above exonic regions indicate probes. Striped boxes
represent novel exon candidates. (b) Typical result of RecA-mediated exon
profiling method. The probe 3 was designed on a novel exon candidate.
Circles and crosses indicate the presence and the absence of the triplex
formation, respectively. (c) Typical result of RecA-mediated exon profiling
method. The probe 5 was designed on a known exon (exon 4). (d) Exon
structures of three alternative splice candidate transcripts (clones 2, 4 and 13).
Closed boxes and lines indicate exons and introns, respectively. The clone
IDs for the clones 2, 4 and 13 are indicated at the bottom.
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Following the conﬁrmation of newly identiﬁed variants by
sequencing, we characterized them with several analyses.
The InterPro analysis indicated that the known Txndc5
cDNA has a Thioredoxin domain 2 (IPR: 006663), expanding
between exon 1 and exon 9. Out of the 25 clones clustered in
this locus, on the other hand, 21 clones lacked the exon 1 or
used an alternative exonic region as exon 1 (50-most exon),
implying the alteration of function for novel splice variants.
Consistentwiththisobservation,theSOSUIprogrampredicted
that the cDNA containing the known exon 1 carried a signal
peptideandwasaninsolubleprotein,butthesplicevariantlack-
ing the exon 1 became soluble without the signal peptide.
IL-1b is a well-known cytokine with various important bio-
logical functions. It has been reported to be a central mediator
of inﬂammation and connective tissue destruction in rheuma-
toid arthritis. The IL-1b activates articular chondrocytes to
produce matrix metalloproteinase-1 (MMP-1), which is capa-
ble of dismantling the collagen scaffold of articular cartilage
(39). Within the IL-1b locus, two novel splice patterns were
identiﬁed as mentioned above. One of these lacked ﬁrst 4
exons, implying a truncated clone. To make sure whether it
is a truncated cDNA or not, the sequence of this clone was
compared with the information on transcription start sites
derived from CAGE and GIS tags (40,41). As a result, two
CAGE tags corresponding to the position of 50 end of splice
variant, suggested that this clone should be a full-length
cDNA. In addition, the InterPro analysis indicated that this
short clone lacked the IL-1b domain and had an ‘unintegrated
transmembrane region’ instead (Figures 6a and 7).
IL-1F6 is involved in a wide array of biological activities
that initiate and promote the host response to injury or infec-
tion by activating a set of transcription factors (42). From our
analysis, we found that two clones, which were identical
each other, lack a cytokine IL-1-like domain (IPR: 008996).
The cytokine IL-1 domain is known to have a function in
stimulating mRNA and protein synthesis level of insulin-
like growth factor 1 (IGF-1), possibly promoting the intimal
hyperplasia (43). The novel splice variant, lacking the
Cytokine IL-1-like domain may lead to alteration of tran-
scriptional level or even translational level of IGF-1.
DISCUSSION
In this study, we have developed an effective exon proﬁling
method by utilizing RecA protein. This method allows us
to screen alternatively spliced transcripts/cDNAs from a
cDNA clone set with high accuracy. With this method, we
successfully identiﬁed splice variants from four independent
gene loci.
Recent cDNA projects largely contributed to understand
the complexity of transcriptome to describe its detailed
picture. However, limited number of cDNAs was fully
sequenced, and most of collected cDNAs were clustered
into TUs with their EST information and stored without
being fully sequenced, implying that many of novel splice
variants remain to be sequenced. In our RIKEN cDNA clone
bank, a few million of cDNAs were clustered into 28163
TUs, and 53% (14994 TUs) of all TUs include more than
two clones within each TU. In addition, 18% (5019 TUs)
of all TUs contain >10 clones/TU, and the number of clones
for 163 TUs is >100 entries. In this study, we used 96-well
plates for exon proﬁling, and were able to proﬁle all exon
structures of 95 clones easily. This fact strongly suggests
that our RecA-mediated exon proﬁling method is applicable
to most TUs of RIKEN clone bank. In other words, our
method should be a considerable option for the ﬁrst screening
to identify novel splice variants, especially in the case that
one looks for splice variants of certain genes.
To consider exon proﬁling, PCR technique can be another
possible option. When sequence information about known
exons and candidate exons are available, exon proﬁling can
be carried out by PCR with primers corresponding to exonic
regions. Designing primers for PCR, however, requires con-
sidering the melting temperature of primers and/or careful
selection to avoid mis-priming of primers. In addition, ends
of exonic regions tend to be conserved (44), and this fact
might cause difﬁculties on designing primers for PCR. In
contrast, our detection method using RecA protein allows
us to design probe DNAs more ﬂexibly because of its
little sequence restriction. Moreover, regardless of probe
sequences, RecA reaction can be simply performed with incu-
bating reaction mixture at 37 C. This ﬂexibility and easiness
of the RecA-mediated method should be advantageous to
proﬁle exon structures.
It should be noted that the RecA-mediated method has
some limitations for exon proﬁling. One possible limitation
is the difﬁculty on designing probes for unknown/novel
exons. In our analysis, novel exon candidates were experi-
mentally extracted from the microarray-based RNA mapping
since the RNAs utilized for cDNA library construction were
available. This successfully led us to identify a novel splice
variant of IL-1b. In contrast, full-length sequencing for
Txndc5 gene showed that two novel splice variants harboring
unknown exons were not detected by the RecA-mediated
method because the corresponding exons were not predicted
as novel exons through RNA mapping. In addition, out
of total 36 novel exon candidates, the sequences of 35 candi-
dates could not be found within any fully sequenced cDNAs
Interleukin 1 beta
Figure 7. Alignment of known transcript, newly identified splice variant and
CAGE tags. CAGE tags are represented with closed arrowheads. Boxes and
lines represent exons and introns, respectively. Closed boxes indicate the
region of protein-coding sequence. Tissue names of origin are indicated.
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rare transcripts were diluted by mixing RNAs and signals for
these transcripts were below the detection limit of microar-
ray. Better prediction for novel exon candidates is required.
In the case that target tissues and genes are determined, the
number of RNA pools to mix can be kept as less as possible,
it would help to improve the prediction for novel exon candi-
dates. However, this might increase the risk of cross
hybridization instead. To compensate, exon prediction pro-
grams such as GENSCAN (45) and Exoniphy (46) should
be utilized for predicting novel exon candidates.
Another possible limitation is the difﬁculty on detecting
exons, which are different in length. It has been known that
many splice variants carry exons, especially 50- and 30-most
exons, which are different in length. In our analysis, one
probe per 100 bp was designed, and our method failed
to detect the difference of exon length for the 50-most and
30-most exons in Txndc5 at 6% (12/190). To detect this
kind of exons more precisely, probes should be designed
more frequently with the help of statistical model (47).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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